Aims & Scope
The Journal of Clinical Endocrinology & Metabolism (JOCEM) is a peer-reviewed, open-access clinical endocrinology and metabolism journal published by Directive Publications. It publishes original research, reviews, and case reports spanning the diagnosis, mechanisms, and management of endocrine and metabolic disease, with a translational emphasis that connects laboratory discovery to bedside practice for clinicians, endocrinologists, and biomedical researchers.
Core coverage includes diabetes mellitus and incretin-based therapeutics (GLP-1 receptor agonists, tirzepatide, semaglutide), obesity and metabolic syndrome, and lipid and lipoprotein disorders such as dysbetalipoproteinemia. The journal has notable depth in adrenal disease and steroidogenesis, including congenital adrenal hyperplasia, primary adrenal insufficiency, and HPA-axis and cortisol dysregulation, alongside thyroid, pituitary, and reproductive endocrinology.
We welcome studies using clinical trials, observational cohorts, endocrine diagnostics (immunoassays, imaging, ultrasonography), and emerging methods such as single-cell sequencing. Submissions are evaluated by rigorous double-blind peer review.
Accepted articles are published open access under a Creative Commons CC-BY 4.0 licence with authors retaining copyright. The journal follows COPE ethical principles.
Subject Coverage
Journal of Clinical Endocrinology and Metabolism welcomes original research, reviews, and case reports across the following core areas:
Research Topics
Core subject areas published in Journal of Clinical Endocrinology and Metabolism — explore related research across our journals.
Articles
A Randomized, Multicentric, Double-Blind, Active Controlled, Parallel Group, Phase III, Non-Inferiority Clinical Trial To Evaluate The Efficacy, Safety And Tolerability Of Oral Semaglutide Tablets Of Dr. Reddy’s Laboratories Ltd. Compared With Rybelsus® (Semaglutide) Tablets In Adult Patients With Inadequately Controlled Type 2 Diabetes Mellitus.
Thyroid Hormone Parameters During Cancer Treatment In Children: Results Of The Thyro-Dynamics Study
Ultrasonographic Changes Of The Malar Adipose Panniculus Assessing The Endocrine Response After Facial Adipoestructuration
Single-Cell Sequencing Reveals a Regulatory Role of WT1 in Mast Cell Proliferation in Endometrial Polyps
Possible Effects of the COVID-19 Pandemic on the Prevalence of Malnutrition-Anorexia Cases in a Pediatric Population. Using Big Data Tools
Mathematical method for determining the critical size of a lymph node Using Ultrasonography
Long-Term Safety of Tirzepatide (Mounjaro): Relationship Between Duration of Use and Adverse Events Compared With Semaglutide and Liraglutide
Exploring the diagnostic association between cortisol and DHEA-S concentrations in patients experiencing chronic depressive disorders
Editorial Board
Peer review for this journal is governed under COPE principles by an editorial board of 2 members.
View Editorial Board (2) →Frequently Asked Questions
What topics does the Journal of Clinical Endocrinology & Metabolism cover?
JOCEM publishes clinical and translational research across endocrinology and metabolism, including diabetes and incretin therapeutics (GLP-1 receptor agonists, tirzepatide, semaglutide), obesity and metabolic syndrome, adrenal disorders such as congenital adrenal hyperplasia and adrenal insufficiency, HPA-axis and cortisol dysregulation, thyroid and pituitary disease, and lipid and cardiometabolic disorders.
Who should read or publish in the Journal of Clinical Endocrinology & Metabolism?
The journal serves clinical endocrinologists, diabetologists, internists, endocrine researchers, and trainees who study or manage hormonal and metabolic disease. Authors investigating endocrine diagnostics, steroidogenesis, obesity pharmacotherapy, or HPA-axis physiology are encouraged to submit original research, reviews, and case reports.
Is the Journal of Clinical Endocrinology & Metabolism open access, and who holds the copyright?
Yes. Every accepted article is published open access under a Creative Commons CC-BY 4.0 licence, and authors retain copyright. Articles are free to read, download, and reuse with attribution, maximising the visibility and citability of your endocrinology and metabolism research.
What article types does the Journal of Clinical Endocrinology & Metabolism accept?
JOCEM accepts original research articles, systematic and narrative reviews, clinical case reports (for example primary adrenal insufficiency or congenital adrenal hyperplasia), short communications, and editorials addressing clinical endocrinology and metabolic medicine.
How does peer review work at the Journal of Clinical Endocrinology & Metabolism?
All submissions undergo double-blind peer review, where author and reviewer identities are concealed to ensure impartial assessment. Reviewers evaluate scientific rigour, methodology, ethics, and clinical relevance, and the journal follows COPE ethical principles throughout the editorial process.
Is there an article-processing charge, and are waivers available?
An article-processing charge applies on acceptance to sustain open-access publication; there is no charge to submit. Waivers and discounts are available for authors with limited funding, including early-career and low-resource researchers. Contact the editorial office for current details before submission.
How do I submit a manuscript to the Journal of Clinical Endocrinology & Metabolism?
Prepare your manuscript according to the author guidelines, confirm it falls within the journal's endocrinology and metabolism scope, and submit through the journal's submission page. Studies on diabetes, obesity, adrenal disease, and the HPA axis are especially welcome.